New research in The FASEB Journal suggests that an abnormal amount of an inflammatory protein called PAR2 is present on abdominal fat tissues of overweight and obese humans and rats
Scientists have moved a step closer to an “obesity drug” that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that there is an abnormal amount of an inflammatory protein called PAR2 in the abdominal fat tissue of overweight and obese humans and rats. This protein is also increased on the surfaces of human immune cells by common fatty acids in the diet. When obese rats on a diet high in sugar and fat were given a new oral drug that binds to PAR2, the inflammation-causing properties of this protein were blocked, as were other effects of the high-fat and high-sugar diet–including obesity itself.
“This important new finding links obesity and high fat high sugar diets with changes in immune cells and inflammatory status, highlighting an emerging realization that obesity is an inflammatory disease,” said David P. Fairlie, Ph.D., study author from the Institute for Molecular Bioscience at the University of Queensland, in Bribane, Australia. “Drugs designed to block certain inflammatory proteins, as in this report, may be able to prevent and treat obesity, which in turn is a major risk factor for type 2 diabetes, heart disease, stroke, kidney failure, limb amputation, and cancers.”
To make this discovery, Fairlie and colleagues discovered the first potent, selective and orally bioavailable small molecule antagonists of PAR2 and characterized their functional responses in inflammatory cellular and animal models. They found that PAR2 expression is increased in vivo in adipose tissue from obese humans and rats, stimulated in vitro in human macrophages by the dietary fatty acid palmitic acid, and inhibited in vivo and in vitro by a PAR2 antagonist. This antagonist was then used as a tool to dissect roles for PAR2 activation in mediating metabolic dysfunction in human monocyte-derived macrophages (HMDM), human and rodent adipocytes, and diet-induced obesity in rats. Oral treatment of diet-induced obese rats attenuated PAR2 signaling in adipose tissue and inhibited adipose inflammation, insulin resistance, diet-induced obesity and cardiovascular abnormalities. This is the first report that a PAR2 antagonist improves obesity, glucose homeostasis and obesity-associated chronic inflammation in vivo. These findings indicate that increased PAR2 expression may be a valuable new biomarker for metabolic dysfunction and further, that PAR2 antagonism can be an effective intervention for treating metabolic dysfunction and obesity.
“We know that that eating too much and not exercising enough makes you overweight, and then obese, but why? The bottom line of this report is that obesity is an inflammatory disease, and inflammation plays a greater role in the downward spiral to obesity than most people realize.” said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. “It appears that once we can control the inflammation, we can begin to get everything else in line. Fortunately, these scientists have already identified one promising compound that seems to work.”
The Latest on: Obesity is an inflammatory disease
- FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweighton April 26, 2024 at 9:58 am
The U.S. Food and Drug Administration recently approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults with ...
- Understanding the cellular mechanisms of obesity-induced inflammation and metabolic dysfunctionon April 25, 2024 at 6:27 am
A South Korean team has spearheaded a research endeavor that successfully uncovered the mechanisms governing inflammation and metabolic dysfunction in tissues associated with obesity. Their findings ...
- 3 Foods That Make It Ridiculously Hard to Lose Belly Fat, According to Obesity Medicine Docson April 25, 2024 at 3:25 am
"Diet is what contributes to losing or gaining fat," says Dr. Mir Ali, MD, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center. "The ...
- Ipsen gets grant for treatment of diseases with specific benzothiazepine and benzothiadiazepine derivativeson April 24, 2024 at 6:17 am
Discover how Ipsen SA's patented compounds can treat cardiovascular, metabolic, gastrointestinal, and liver diseases. Learn about the method and specific compounds outlined in the recently granted ...
- Researchers Earn $2.3 Million Grant To Study Generational Cycle Of Maternal Obesity, Liver Diseaseon April 23, 2024 at 1:46 am
Research increasingly suggests that when a woman with obesity becomes pregnant, a process of "fetal reprogramming" increases the risk that her baby will face problems like obesity, Type 2 diabetes and ...
- Natural obesity fighters: How coffee, tea, and cocoa combat weight gainon April 22, 2024 at 7:03 pm
A review in Current Research in Food Science explores how bioactive compounds in coffee, tea, and cocoa combat obesity by inhibiting white adipogenesis and promoting brown adipogenesis and lipolysis.
- Obesity Newson April 17, 2024 at 5:00 pm
One reason may be reduced vaccine efficacy in people with obesity than ... as well as common diseases like diabetes, which arise from poor diet. The insights ... Apr. 10, 2024 — Children ...
- How Is Obesity Linked With Higher Risk Of Cancer?on April 17, 2024 at 6:05 am
Obesity is a condition involving excessive fat in your body Read on to learn how it increases the risk of cancer ...
- Obesity drugs aren’t always forever. What happens when you quit?on April 15, 2024 at 5:00 pm
Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off them.
- 'I'm a doctor and I say fasting may help prevent diseases linked to our diet'on April 15, 2024 at 12:46 pm
Miriam Stoppard shares exciting research from Cambridge University that could help reduce inflammation in the body, which is linked to diabetes and heart disease ...
via Bing News
The Latest on: Inflammatory disease
- Imaging using fundus autofluorescence can facilitate the diagnosis and monitoring of rare eye diseaseson April 25, 2024 at 9:27 pm
Uveitis is a rare inflammatory eye disease. Posterior and panuveitis in particular are associated with a poor prognosis and a protracted course of the disease. Diagnosis and monitoring can be ...
- Fecal Transplant Shows Promise for Easing Inflammatory Bowel Disease Symptomson April 25, 2024 at 4:45 pm
For the study, scientists reviewed results from 15 clinical trials that tested fecal microbiota transplants (FMT) — when stool with healthy microorganisms is inserted into a sick patient’s digestive ...
- Medical Moment: The accidental discovery to treat inflammatory bowel diseaseon April 25, 2024 at 2:50 pm
There’s new hope after that same brain enzyme was found in the gut during IBD flareups, opening the door to tackle neuro and gut disease through a simple pill.
- Incyte agrees to acquire skin disease drug developer in $750 million dealon April 25, 2024 at 7:27 am
AdvertisementIncyte has agreed to acquire Escient Pharmaceuticals, a clinical-stage company with a promising dermatology candidate. The price tag is $750 million. “As a company dedicated to innovation ...
- Diagnosis of rare eye diseases: Uveitis experts provide an overview of an underestimated imaging techniqueon April 25, 2024 at 6:51 am
Uveitis is a rare inflammatory eye disease. Posterior and panuveitis in particular are associated with a poor prognosis and a protracted course of the disease. Diagnosis and monitoring can be ...
- Scientists discover the cellular functions of a family of proteins integral to inflammatory diseaseson April 24, 2024 at 1:49 pm
In a scientific breakthrough, researchers have revealed the biological mechanisms by which a family of proteins known as histone deacetylases (HDACs) activate immune system cells linked to ...
- AI tool recognizes serious ocular disease in horseson April 24, 2024 at 12:59 pm
Colloquially known as moon blindness, equine recurrent uveitis (ERU) is an inflammatory ocular disease in horses, which can lead to blindness or loss of the affected eye. It is one of the most common ...
- Single-cell analysis reveals mechanisms of a common complication of Crohn's diseaseon April 24, 2024 at 8:00 am
Mount Sinai researchers have published the first study to use single-cell analysis in identifying several pathophysiological mechanisms of abnormal passageways in the digestive system known as ...
- Existing drugs studied in patients with rare immune diseaseson April 24, 2024 at 5:48 am
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
- What You Need To Know about Crohn's Disease Poopon April 24, 2024 at 2:30 am
Crohn's disease can affect the appearance and smell of your poop. It can also cause changes in your bowel movements, like how often you need to poop.
via Bing News